{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:13:08Z","timestamp":1792239188243,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1245\/s10434-015-4379-5","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T11:58:31Z","timestamp":1422014311000},"page":"1556-1565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer"],"prefix":"10.1245","volume":"22","author":[{"given":"Sheng-Mou","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hsien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Tai","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Liang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Hung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"4379_CR1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1242\/jcs.00493","volume":"116","author":"M Lachner","year":"2003","unstructured":"Lachner M, O\u2019Sullivan RJ, Jenuwein T. An epigenetic road map for histone lysine methylation. J Cell Sci. 2003;116:2117\u201324.","journal-title":"J Cell Sci."},{"key":"4379_CR2","doi-asserted-by":"crossref","first-page":"25309","DOI":"10.1074\/jbc.M101914200","volume":"276","author":"M Tachibana","year":"2001","unstructured":"Tachibana M, Sugimoto K, Fukushima T, Shinkai Y. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem. 2001;276:25309\u201317.","journal-title":"J Biol Chem."},{"key":"4379_CR3","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/emboj.2008.192","volume":"27","author":"M Tachibana","year":"2008","unstructured":"Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y. G9a\/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. Embo J. 2008;27:2681\u201390.","journal-title":"Embo J."},{"key":"4379_CR4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.2027411","volume":"25","author":"Y Shinkai","year":"2011","unstructured":"Shinkai Y, Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev. 2011;25:781\u20138.","journal-title":"Genes Dev."},{"key":"4379_CR5","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1074\/jbc.M109.062588","volume":"285","author":"J Huang","year":"2010","unstructured":"Huang J, Dorsey J, Chuikov S, et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem. 2010;285:9636\u201341.","journal-title":"J Biol Chem."},{"key":"4379_CR6","doi-asserted-by":"crossref","first-page":"e2037","DOI":"10.1371\/journal.pone.0002037","volume":"3","author":"Y Kondo","year":"2008","unstructured":"Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR, Issa JP. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. Plos One. 2008;3:e2037.","journal-title":"Plos One."},{"key":"4379_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","volume":"118","author":"Y Kang","year":"2004","unstructured":"Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118:277\u20139.","journal-title":"Cell."},{"key":"4379_CR8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm1699","volume":"6","author":"BM Gumbiner","year":"2005","unstructured":"Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005;6:622\u201334.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4379_CR9","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.2006419","volume":"251","author":"M Takeichi","year":"1991","unstructured":"Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451\u20135.","journal-title":"Science."},{"key":"4379_CR10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","volume":"4","author":"U Cavallaro","year":"2004","unstructured":"Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004;4:118\u201332.","journal-title":"Nat Rev Cancer."},{"key":"4379_CR11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1172\/JCI0215429","volume":"109","author":"M Conacci-Sorrell","year":"2002","unstructured":"Conacci-Sorrell M, Zhurinsky J, Ben-Ze\u2019ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109:987\u201391.","journal-title":"J Clin Invest."},{"key":"4379_CR12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/gyno.1994.1113","volume":"53","author":"N Sakuragi","year":"1994","unstructured":"Sakuragi N, Nishiya M, Ikeda K, et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 1994;53:183\u20139.","journal-title":"Gynecol Oncol."},{"key":"4379_CR13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0029-7844(02)02391-8","volume":"100","author":"K Holcomb","year":"2002","unstructured":"Holcomb K, Delatorre R, Pedemonte B, McLeod C, Anderson L, Chambers J. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Obstet Gynecol. 2002;100:1290\u20135.","journal-title":"Obstet Gynecol."},{"key":"4379_CR14","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-0943-03","volume":"10","author":"LK Mell","year":"2004","unstructured":"Mell LK, Meyer JJ, Tretiakova M, et al. Prognostic significance of E-cadherin protein expression in pathological stage I\u2013III endometrial cancer. Clin Cancer Res. 2004;10:5546\u201353.","journal-title":"Clin Cancer Res."},{"key":"4379_CR15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI57349","volume":"122","author":"C Dong","year":"2012","unstructured":"Dong C, Wu Y, Yao J, et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest. 2012;122:1469\u201386.","journal-title":"J Clin Invest."},{"key":"4379_CR16","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1158\/0008-5472.CAN-10-0833","volume":"70","author":"MW Chen","year":"2010","unstructured":"Chen MW, Hua KT, Kao HJ, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010;70:7830\u201340.","journal-title":"Cancer Res."},{"key":"4379_CR17","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/sj.onc.1208991","volume":"24","author":"YN Liu","year":"2005","unstructured":"Liu YN, Lee WW, Wang CY, et al. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 2005;24:8277\u201390.","journal-title":"Oncogene."},{"key":"4379_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/onc.2012.76","volume":"32","author":"A Yeramian","year":"2013","unstructured":"Yeramian A, Moreno-Bueno G, Dolcet X, et al. Endometrial carcinoma: molecular alterations involved in tumor development and progression. Oncogene. 2013;32:403\u201313.","journal-title":"Oncogene."},{"key":"4379_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.onc.1209763","volume":"26","author":"RJ Wozniak","year":"2007","unstructured":"Wozniak RJ,\u00a0Klimecki WT,\u00a0Lau SS,\u00a0Feinstein Y,\u00a0Futscher BW. 5-Aza-2\u2019-deoxycytidine-mediated reductions in\u00a0G9A\u00a0histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene.\u00a02007;26:77\u201390.","journal-title":"Oncogene."},{"key":"4379_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4161\/epi.5.6.12431","volume":"5","author":"MH Tao","year":"2010","unstructured":"Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics. 2010;5:491\u20138.","journal-title":"Epigenetics."},{"key":"4379_CR21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","volume":"379","author":"JD Wright","year":"2012","unstructured":"Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet. 2012;379:1352\u201360.","journal-title":"Lancet."},{"key":"4379_CR22","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer. 1987;60:2035\u201341.","journal-title":"Cancer."},{"key":"4379_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","volume":"40","author":"CP Morrow","year":"1991","unstructured":"Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55\u201365.","journal-title":"Gynecol Oncol."},{"key":"4379_CR24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humpath.2011.06.021","volume":"43","author":"N Montserrat","year":"2012","unstructured":"Montserrat N, Mozos A, Llobet D, et al. Epithelial-to-mesenchymal transition in early-stage endometrioid endometrial carcinoma. Hum Pathol. 2012;43:632\u201343.","journal-title":"Hum Pathol."},{"key":"4379_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/07357907.2010.512603","volume":"29","author":"TZ Yi","year":"2011","unstructured":"Yi TZ, Guo J, Zhou L, et al. Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma. Cancer Invest. 2011;29:86\u201392.","journal-title":"Cancer Invest."},{"key":"4379_CR26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/cncr.11157","volume":"97","author":"T Saito","year":"2003","unstructured":"Saito T, Nishimura M, Yamasaki H, Kudo R. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Cancer. 2003;97:1002\u20139.","journal-title":"Cancer."},{"key":"4379_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng0594-98","volume":"7","author":"JI Risinger","year":"1994","unstructured":"Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet. 1994;7:98\u2013102.","journal-title":"Nat Genet."},{"key":"4379_CR28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/PDM.0b013e31806219ae","volume":"16","author":"K Blechschmidt","year":"2007","unstructured":"Blechschmidt K, Kremmer E, Hollweck R, Mylonas I, H\u00f6fler H, Kremer M, Becker KF. The E-cadherin repressor Snail plays a role in tumor progression of endometrioid adenocarcinomas. Diagn Mol Pathol. 2007;16:222\u20138.","journal-title":"Diagn Mol Pathol."},{"key":"4379_CR29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/modpathol.2008.82","volume":"21","author":"M Singh","year":"2008","unstructured":"Singh M, Spoelstra NS, Jean A, et al. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol. 2008;21:912\u201323.","journal-title":"Mod Pathol."},{"key":"4379_CR30","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/1078-0432.CCR-08-2784","volume":"15","author":"MT McCabe","year":"2009","unstructured":"McCabe MT, Brandes JC, Vertino PM. Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res. 2009;15:3927\u201337.","journal-title":"Clin Cancer Res."},{"key":"4379_CR31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1349-7006.2008.00743.x","volume":"99","author":"S Fujii","year":"2008","unstructured":"Fujii S, Ochiai A. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci. 2008;99:738\u201346.","journal-title":"Cancer Sci."},{"key":"4379_CR32","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","volume":"27","author":"Q Cao","year":"2008","unstructured":"Cao Q, Yu J, Dhanasekaran SM, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008;27:7274\u201384.","journal-title":"Oncogene."},{"key":"4379_CR33","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1074\/jbc.M109.073676","volume":"285","author":"K Rai","year":"2010","unstructured":"Rai K, Jafri IF, Chidester S, James SR, Karpf AR, Cairns BR, Jones DA. Dnmt3 and G9a cooperate for tissue-specific development in zebra fish. J Biol Chem. 2010;285:4110\u201321.","journal-title":"J Biol Chem."},{"key":"4379_CR34","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1101\/gad.1463706","volume":"20","author":"PO Esteve","year":"2006","unstructured":"Esteve PO, Chin HG, Smallwood A, et al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 2006;20:3089\u2013103.","journal-title":"Genes Dev."},{"key":"4379_CR35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vire","year":"2006","unstructured":"Vire E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439:871\u20134.","journal-title":"Nature."},{"key":"4379_CR36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/439794a","volume":"439","author":"P Taghavi","year":"2006","unstructured":"Taghavi P, van Lohuizen M. Developmental biology: two paths to silence merge. Nature. 2006;439:794\u20135.","journal-title":"Nature."},{"key":"4379_CR37","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nsmb.1476","volume":"15","author":"S Epsztejn-Litman","year":"2008","unstructured":"Epsztejn-Litman S, Feldman N, Abu-Remaileh M, et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol. 2008;15:1176\u201383.","journal-title":"Nat Struct Mol Biol."},{"key":"4379_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1535-6108(02)00234-9","volume":"3","author":"KE Bachman","year":"2003","unstructured":"Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell. 2003;3:89\u201395.","journal-title":"Cancer Cell."},{"key":"4379_CR39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ncb1353","volume":"8","author":"N Feldman","year":"2006","unstructured":"Feldman N, Gerson A, Fang J, et al. G9a-mediated irreversible epigenetic inactivation of Oct-3\/4 during early embryogenesis. Nat Cell Biol. 2006;8:188\u201394.","journal-title":"Nat Cell Biol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4379-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4379-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4379-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:24:38Z","timestamp":1559633078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4379-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":39,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4379"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4379-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]}}}